An Outpatient, Platinum-Free, Oral Arsenic Chemotherapy Modality for Advanced Recurrent Epithelial Ovarian Cancer: A Report of Two Cases

1. Abstract

Recurrent epithelial ovarian cancer is generally associated with platinum resistance and poor prognosis. Although there are many single-drug chemotherapy regimens, the response rate is low.